Therapy Areas: Inflammatory Diseases
Cyxone (publ) names new senior scientific Aadvisor
7 July 2020 -

Cyxone (publ), a Sweden-based biotech company, has named Dr Maarten Kraan as its new senior scientific advisor for the company's project for Rabeximod in rheumatoid arthritis, it was reported on Monday.

Dr Kraan is a board-certified rheumatologist and holds a medical degree and PhD in immunology from Leiden University.

Dr Kraan has held various management positions within drug research, clinical development and regulatory affairs in pharmaceutical companies in both Europe and USA.

Login
Username:

Password: